India · Delayed Price · Currency is INR NSE:AAREYDRUGS Statistics
Total Valuation
NSE:AAREYDRUGS has a market cap or net worth of INR 1.62 billion. The enterprise value is 2.10 billion.
| Market Cap | 1.62B |
| Enterprise Value | 2.10B |
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 28.45M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.03% |
| Owned by Institutions (%) | 2.78% |
| Float | 13.23M |
Valuation Ratios
The trailing PE ratio is 47.03.
| PE Ratio | 47.03 |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 61.22 |
| EV / Sales | 0.54 |
| EV / EBITDA | 84.03 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 22.76 |
| Debt / FCF | n/a |
| Interest Coverage | 0.11 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.11% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.33% |
| Revenue Per Employee | 29.61M |
| Profits Per Employee | 260,227 |
| Employee Count | 132 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:AAREYDRUGS has paid 23.24 million in taxes.
| Income Tax | 23.24M |
| Effective Tax Rate | 40.36% |
Stock Price Statistics
The stock price has increased by +18.29% in the last 52 weeks. The beta is 0.80, so NSE:AAREYDRUGS's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +18.29% |
| 50-Day Moving Average | 67.25 |
| 200-Day Moving Average | 72.51 |
| Relative Strength Index (RSI) | 40.73 |
| Average Volume (20 Days) | 100,437 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AAREYDRUGS had revenue of INR 3.91 billion and earned 34.35 million in profits. Earnings per share was 1.19.
| Revenue | 3.91B |
| Gross Profit | 65.46M |
| Operating Income | 3.73M |
| Pretax Income | 57.59M |
| Net Income | 34.35M |
| EBITDA | 25.03M |
| EBIT | 3.73M |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 81.90 million in cash and 569.60 million in debt, with a net cash position of -487.70 million.
| Cash & Cash Equivalents | 81.90M |
| Total Debt | 569.60M |
| Net Cash | -487.70M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 53.06 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 21.30M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 1.67%, with operating and profit margins of 0.10% and 0.88%.
| Gross Margin | 1.67% |
| Operating Margin | 0.10% |
| Pretax Margin | 1.47% |
| Profit Margin | 0.88% |
| EBITDA Margin | 0.64% |
| EBIT Margin | 0.10% |
| FCF Margin | n/a |
Dividends & Yields
NSE:AAREYDRUGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.15% |
| Shareholder Yield | -4.15% |
| Earnings Yield | 2.13% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |